The Max Foundation Releases Video from Global Experience

The Max Foundation Releases Video from Global Experience

Put on by The Max Foundation in August of 2018, the Max Global Experience Uganda was a fundraising and engagement opportunity for patient leaders, industry partners, and Max team members to come together to expand access to cancer treatment in Africa. The global experience included an all-day symposium, a visit to the Uganda Cancer Institute, and a “last mile” walk along the Nile in solidarity with patients across Africa. The video was put together using interviews filmed during the experience and includes patient leaders, industry partners, and Max team members alike. To learn more about the Max Global Experience, watch the video below or read this post.

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The Max Foundation Welcomes New Member to Executive Team

    The Max Foundation Welcomes New Member to Executive Team

    The Max Foundation is thrilled to announce the hiring of Patricia Pearce as Chief Financial Officer (CFO) and Vice President (VP) of Administration. She joins the team at our Seattle headquarters beginning on Monday, July 30th, 2018.

  • The Max Foundation Expands Agreement with Bristol-Myers Squibb

    The Max Foundation Expands Agreement with Bristol-Myers Squibb

    The Max Foundation is proud to announce it has signed an expanded collaboration agreement with Bristol-Myers Squibb – a committed pharmaceutical partner and member of our humanitarian pact.

  • The Max Foundation Partners with Leading Pharmaceutical Company to Advance Health Equity Through Expanded CML Treatment Access for Patients in 36 Low-Middle-Income Countries

    Availability of Novartis Scemblix® (asciminib) starting in 2023 helps ensure people living with later lines of CML in low-income countries have access to the latest innovation SEATTLE – Dec. 12, 2022 – The Max Foundation (Max), a global nonprofit organization that aims to accelerate health equity by delivering medication, technology, and supportive services to patients globally,….